HRMY CIK: 1802665

Harmony Biosciences Holdings, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
250
FY22:
354
FY23:
461
FY24:
558
FY25:
670
(positive)
Change from FY21 to FY25
millions USD
FY21:
87.5
FY22:
120
FY23:
192
FY24:
191
FY25:
208
(positive)
Change from FY21 to FY25
millions USD
FY21:
107
FY22:
147
FY23:
231
FY24:
233
FY25:
255
(positive)
Change from FY21 to FY25
millions USD
FY21:
37.4
FY22:
105
FY23:
173
FY24:
192
FY25:
215
(positive)
Change from FY21 to FY25
millions USD
FY21:
34.6
FY22:
181
FY23:
129
FY24:
145
FY25:
159

All amounts in millions USD Data sources:SEC EDGARTwelve Data